Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
February-2018 Volume 41 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2018 Volume 41 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study

  • Authors:
    • Yeseung Lee
    • Aryo Dimas Pamungkas
    • Carl Angelo D. Medriano
    • Jinsung Park
    • Seri Hong
    • Sun Ha Jee
    • Youngja H. Park
  • View Affiliations / Copyright

    Affiliations: Metabolomics Laboratory, College of Pharmacy, Korea University, Sejong City 30019, Republic of Korea, Department of Control and Instrumentation on Engineering, Korea University, Sejong City 30019, Republic of Korea, Department of Epidemiology and Health Promotion and Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul 03722, Republic of Korea
  • Pages: 1069-1077
    |
    Published online on: November 21, 2017
       https://doi.org/10.3892/ijmm.2017.3275
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Type 2 diabetes mellitus (DM) is a progressive disease and the rate of progression from non-diabetes to DM varies considerably between individuals, ranging from a few months to many years. It is important to understand the mechanisms underlying the progression of diabetes. In the present study, a high-resolution metabolomics (HRM) analysis was performed to detect potential biomarkers and pathways regulating the mode of onset by comparing subjects who developed and did not develop type 2 DM at the second year in a 3-year prospective cohort study. Metabolic profiles correlated with progression to DM were examined. The subjects (n=98) were classified into four groups: Control (did not develop DM for 3 years), DM (diagnosed with DM at the start of the study), DM onset at the third year and DM onset at the second year. The focus was on the comparison of serum samples of the DM groups with onset at the second and third year from the first year, where these two groups had not developed DM, yet. Analyses involved sample examination using liquid chromatography-mass spectrometry-based HRM and multivariate statistical analysis of the data. Metabolic differences were identified across all analyses with the affected pathways involved in metabolism associated with steroid biosynthesis and bile acid biosynthesis. In the first year, higher levels of cholesterol {mass-to charge ratio (m/z) 369.35, (M+H-H2O)+}, 25-hydroxycholesterol [m/z 403.36, (M+H)+], 3α,7α-dihydroxy-5β-cholestane [m/z 443.33, (M+K)+], 4α-methylzymosterol-4-carboxylate [m/z 425.34, (M+H‑H2O)+], and lower levels of 24,25-dihydrolanosterol [m/z 429.40, (M+H)+] were evident in the group with DM onset at the second year compared with those in the group with DM onset at the third year. These results, with a focus on the cholesterol biosynthesis pathway, point to important aspects in the development of DM and may aid in the development of more effective means of treatment and prevention.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 28(Suppl 1): S37–S42. 2005. View Article : Google Scholar

2 

Flier JS, Underhill LH, Polonsky KS, Sturis J and Bell GI: Non-insulin-dependent diabetes mellitus-A genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med. 334:777–783. 1996. View Article : Google Scholar

3 

Whiting DR, Guariguata L, Weil C and Shaw J: IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 94:311–321. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Ling C and Groop L: Epigenetics: A molecular link between environmental factors and type 2 diabetes. Diabetes. 58:2718–2725. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Mahajan A, Go MJ, Zhang W, Below JE, Gaulton KJ, Ferreira T, Horikoshi M, Johnson AD, Ng MC, Prokopenko I, et al DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium; Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; Mexican American Type 2 Diabetes (MAT2D) Consortium; Type 2 Diabetes Genetic Exploration by Nex-generation sequencing in muylti-Ethnic Samples (T2D-GENES) Consortium: Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 46:234–244. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, et al MAGIC investigators; GIANT Consortium: Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 42:579–589. 2010. View Article : Google Scholar : PubMed/NCBI

7 

Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM and Stern MP: Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes. 53:160–165. 2004. View Article : Google Scholar

8 

Zhou K, Donnelly LA, Morris AD, Franks PW, Jennison C, Palmer CN and Pearson ER: Clinical and genetic determinants of progression of type 2 diabetes: A DIRECT study. Diabetes Care. 37:718–724. 2014. View Article : Google Scholar :

9 

Mamas M, Dunn WB, Neyses L and Goodacre R: The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol. 85:5–17. 2011. View Article : Google Scholar

10 

Kaddurah-Daouk R, Kristal BS and Weinshilboum RM: Metabolomics: A global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 48:653–683. 2008. View Article : Google Scholar : PubMed/NCBI

11 

Wilson ID, Nicholson JK, Castro-Perez J, Granger JH, Johnson KA, Smith BW and Plumb RS: High resolution 'ultra performance' liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res. 4:591–598. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Guo K, Bamforth F and Li L: Qualitative metabolome analysis of human cerebrospinal fluid by 13C-/12C-isotope dansylation labeling combined with liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom. 22:339–347. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Nicholson JK and Lindon JC: Systems biology: Metabonomics. Nature. 455:1054–1056. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Lee Y, Khan A, Hong S, Jee SH and Park YH: A metabolomic study on high-risk stroke patients determines low levels of serum lysine metabolites: A retrospective cohort study. Mol Biosyst. 13:1109–1120. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar

16 

Suhre K: Metabolic profiling in diabetes. J Endocrinol. 221:R75–R85. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, et al: A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9:311–326. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, et al: Metabolite profiles and the risk of developing diabetes. Nat Med. 17:448–453. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, Heim K, Campillos M, Holzapfel C, Thorand B, et al: Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. 8:6152012. View Article : Google Scholar : PubMed/NCBI

20 

Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, Palma MJ, Roberts LD, Dejam A, Souza AL, et al: Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 125:2222–2231. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Drogan D, Dunn WB, Lin W, Buijsse B, Schulze MB, Langenberg C, Brown M, Floegel A, Dietrich S, Rolandsson O, et al: Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. Clin Chem. 61:487–497. 2015. View Article : Google Scholar

22 

Anjana RM, Shanthi Rani CS, Deepa M, Pradeepa R, Sudha V, Divya Nair H, Lakshmipriya N, Subhashini S, Binu VS, Unnikrishnan R, et al: Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-Year follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care. 38:1441–1448. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Jee SH, Batty GD, Jang Y, Oh DJ, Oh BH, Lee SH, Park SW, Seung KB, Kimm H, Kim SY, et al: The Korean Heart Study: Rationale, objectives, protocol, and preliminary results for a new prospective cohort study of 430,920 men and women. Eur J Prev Cardiol. 21:1484–1492. 2014. View Article : Google Scholar

24 

Want EJ, O'Maille G, Smith CA, Brandon TR, Uritboonthai W, Qin C, Trauger SA and Siuzdak G: Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal Chem. 78:743–752. 2006. View Article : Google Scholar : PubMed/NCBI

25 

Yu T, Park Y, Johnson JM and Jones DP: apLCMS - adaptive processing of high-resolution LC/MS data. Bioinformatics. 25:1930–1936. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. JR Stat Soc B. B57:289–300. 1995.

27 

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI

28 

Smith CA, O'Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R and Siuzdak G: METLIN: A metabolite mass spectral database. Ther Drug Monit. 27:747–751. 2005. View Article : Google Scholar

29 

Prawitt J, Caron S and Staels B: Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep. 11:160–166. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Li T, Francl JM, Boehme S, Ochoa A, Zhang Y, Klaassen CD, Erickson SK and Chiang JY: Glucose and insulin induction of bile acid synthesis: Mechanisms and implication in diabetes and obesity. J Biol Chem. 287:1861–1873. 2012. View Article : Google Scholar :

31 

Tomkin GH and Owens D: Obesity diabetes and the role of bile acids in metabolism. J Transl Int Med. 4:73–80. 2016. View Article : Google Scholar

32 

Russell DW: Cholesterol biosynthesis and metabolism. Cardiovasc Drugs Ther. 6:103–110. 1992. View Article : Google Scholar : PubMed/NCBI

33 

Simons K and Ikonen E: How cells handle cholesterol. Science. 290:1721–1726. 2000. View Article : Google Scholar : PubMed/NCBI

34 

Fernández C, Suárez Y, Ferruelo AJ, Gómez-Coronado D and Lasunción MA: Inhibition of cholesterol biosynthesis by Delta22-unsaturated phytosterols via competitive inhibition of sterol Delta24-reductase in mammalian cells. Biochem J. 366:109–119. 2002. View Article : Google Scholar : PubMed/NCBI

35 

Luu W, Zerenturk EJ, Kristiana I, Bucknall MP, Sharpe LJ and Brown AJ: Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis. J Lipid Res. 55:410–420. 2014. View Article : Google Scholar :

36 

Berisha SZ, Serre D, Schauer P, Kashyap SR and Smith JD: Changes in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: A pilot study. PLoS One. 6:e167292011. View Article : Google Scholar : PubMed/NCBI

37 

Dai M, Zhu XL, Liu F, Xu QY, Ge QL, Jiang SH, Yang XM, Li J, Wang YH, Wu QK, et al: Cholesterol synthetase DHCR24 induced by insulin aggravates cancer invasion and progesterone resistance in endometrial carcinoma. Sci Rep. 7:414042017. View Article : Google Scholar : PubMed/NCBI

38 

Moh A, Zhang W, Yu S, Wang J, Xu X, Li J and Fu XY: STAT3 sensitizes insulin signaling by negatively regulating glycogen synthase kinase-3 beta. Diabetes. 57:1227–1235. 2008. View Article : Google Scholar : PubMed/NCBI

39 

Weyer C, Bogardus C, Mott DM and Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 104:787–794. 1999. View Article : Google Scholar : PubMed/NCBI

40 

Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE and Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 86:1930–1935. 2001. View Article : Google Scholar : PubMed/NCBI

41 

Schiller J, Zschörnig O, Petković M, Müller M, Arnhold J and Arnold K: Lipid analysis of human HDL and LDL by MALDI-TOF mass spectrometry and (31)P-NMR. J Lipid Res. 42:1501–1508. 2001.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lee Y, Pamungkas AD, Medriano CA, Park J, Hong S, Jee SH and Park YH: High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study. Int J Mol Med 41: 1069-1077, 2018.
APA
Lee, Y., Pamungkas, A.D., Medriano, C.A., Park, J., Hong, S., Jee, S.H., & Park, Y.H. (2018). High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study. International Journal of Molecular Medicine, 41, 1069-1077. https://doi.org/10.3892/ijmm.2017.3275
MLA
Lee, Y., Pamungkas, A. D., Medriano, C. A., Park, J., Hong, S., Jee, S. H., Park, Y. H."High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study". International Journal of Molecular Medicine 41.2 (2018): 1069-1077.
Chicago
Lee, Y., Pamungkas, A. D., Medriano, C. A., Park, J., Hong, S., Jee, S. H., Park, Y. H."High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study". International Journal of Molecular Medicine 41, no. 2 (2018): 1069-1077. https://doi.org/10.3892/ijmm.2017.3275
Copy and paste a formatted citation
x
Spandidos Publications style
Lee Y, Pamungkas AD, Medriano CA, Park J, Hong S, Jee SH and Park YH: High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study. Int J Mol Med 41: 1069-1077, 2018.
APA
Lee, Y., Pamungkas, A.D., Medriano, C.A., Park, J., Hong, S., Jee, S.H., & Park, Y.H. (2018). High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study. International Journal of Molecular Medicine, 41, 1069-1077. https://doi.org/10.3892/ijmm.2017.3275
MLA
Lee, Y., Pamungkas, A. D., Medriano, C. A., Park, J., Hong, S., Jee, S. H., Park, Y. H."High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study". International Journal of Molecular Medicine 41.2 (2018): 1069-1077.
Chicago
Lee, Y., Pamungkas, A. D., Medriano, C. A., Park, J., Hong, S., Jee, S. H., Park, Y. H."High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study". International Journal of Molecular Medicine 41, no. 2 (2018): 1069-1077. https://doi.org/10.3892/ijmm.2017.3275
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team